Deka Bank Deutsche Girozentrale Pacira Bio Sciences, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 27,515 shares of PCRX stock, worth $567,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,515

Previous 27,515 -0.0%

Holding current value

$567,909

Previous $767,000 49.15%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$60.03 - $76.49 $150,075 - $191,225	2,500 Added 9.99%	27,515 $2.08 Million
Q4 2021 Feb 02, 2022	BUY	$47.97 - $62.21 $33,579 - $43,547	700 Added 2.88%	25,015 $1.55 Million
Q4 2020 Mar 12, 2021	SELL	$50.47 - $66.26 $615,734 - $808,372	-12,200 Reduced 33.41%	24,315 $1.43 Million
Q3 2020 Oct 29, 2020	BUY	$51.97 - $63.0 $1.9 Million - $2.3 Million	36,515 New	36,515 $2.14 Million
Q4 2019 Feb 04, 2020	SELL	$36.31 - $46.83 $926,449 - $1.19 Million	-25,515 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $966,920 - $1.22 Million	-27,115 Reduced 51.52%	25,515 $1.02 Million
Q2 2019 Aug 01, 2019	BUY	$36.57 - $47.97 $1.17 Million - $1.54 Million	32,082 Added 156.13%	52,630 $2.31 Million
Q1 2019 May 10, 2019	BUY	$36.47 - $42.17 $96,827 - $111,961	2,655 Added 14.84%	20,548 $943,000
Q4 2018 Feb 12, 2019	SELL	$41.31 - $52.16 $109,678 - $138,484	-2,655 Reduced 12.92%	17,893 $744,000
Q3 2018 Nov 09, 2018	BUY	$32.85 - $52.0 $45,760 - $72,436	1,393 Added 7.27%	20,548 $0
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $28,600 - $41,392	1,040 Added 5.74%	19,155 $595,000
Q1 2018 May 03, 2018	SELL	$29.98 - $46.35 $11,992 - $18,540	-400 Reduced 2.16%	18,115 $561,000
Q3 2017 Nov 06, 2017	BUY	$35.7 - $39.5 $660,985 - $731,342	18,515	18,515 $688,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Pacira Bio Sciences, Inc. Transaction History